In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.

In today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the story of their new nonprofit Moonshots for Unicorns, which sets up a framework for parents in their circumstance to directly crowdfund research for rare single-gene disorders – starting with PGAP3.

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. 

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz.

Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patient stories behind the headlines and the effect of COVID-19 on the generics market.

On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss his company’s digital therapeutic for teen depression.

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular design at Silence Therapeutics. 

On the latest installment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio. 

In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, UK and Ireland, Accenture.

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, Vice President of Commercial at US Janssen Neuroscience.